2023
DOI: 10.1097/lvt.0000000000000172
|View full text |Cite
|
Sign up to set email alerts
|

Early neurologic complications after liver transplant are associated with reduced long-term survival and increased rates of rejection

Abstract: Neurologic complications (NCs) are common following liver transplantation (LT) and have been associated with impaired short-term survival. The impact of NC on long-term survival is less defined. We aimed to characterize these outcomes and assess for risk factors for post-LT NC. We performed a single-center, retrospective review of 521 patients with LT from 2016 to 2020. Baseline clinical and laboratory factors, intraoperative events, and outcomes were compared between patients with and without NC. The 5-year o… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 40 publications
(111 reference statements)
0
2
0
Order By: Relevance
“…The grade of encephalopathy before LT has been reported as an important risk factor for neurological complications in previous studies [ 6 , 24 , 25 ]. Patients with alcoholic liver cirrhosis are prone to Wernicke’s encephalopathy with associated seizures [ 26 , 27 ].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…The grade of encephalopathy before LT has been reported as an important risk factor for neurological complications in previous studies [ 6 , 24 , 25 ]. Patients with alcoholic liver cirrhosis are prone to Wernicke’s encephalopathy with associated seizures [ 26 , 27 ].…”
Section: Discussionmentioning
confidence: 99%
“…The frequency of the underlying liver diseases was not statistically different between the groups; however, the seizure group had a higher proportion of patients with alcoholic liver disease than did the control group (39.3% vs. 24.6%). Pretransplant model for endstage liver disease (MELD) score (23)(24)(25)(26)(27)(28)(29)(30)(31)(32) vs.…”
Section: Baseline Characteristicsmentioning
confidence: 99%